Jun Ge

3.0k total citations · 1 hit paper
64 papers, 1.9k citations indexed

About

Jun Ge is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Ge has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Ge's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (5 papers). Jun Ge is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (5 papers). Jun Ge collaborates with scholars based in China, United States and Finland. Jun Ge's co-authors include Binbin Wang, Peng Zhang, Liangdong Sun, Ya Han, Xiaoying Shi, Fan Zhang, Chenfei Wang, Ziyi Li, Jin Wang and Rongbin Zheng and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jun Ge

60 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment

2020 689 citations Dongqing Sun, Jin Wang et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Ge China	19	984	665	506	414	398	64	1.9k
Michael Bergqvist Sweden	27	1.1k 1.1×	873 1.3×	686 1.4×	384 0.9×	579 1.5×	112	2.5k
Bei Lin China	28	1.7k 1.7×	621 0.9×	300 0.6×	593 1.4×	728 1.8×	156	2.8k
Robert Wesolowski United States	29	724 0.7×	1.5k 2.2×	551 1.1×	789 1.9×	354 0.9×	176	2.7k
Jürgen R. Fischer Germany	25	704 0.7×	972 1.5×	632 1.2×	498 1.2×	303 0.8×	70	1.9k
Antje Habel Germany	17	936 1.0×	486 0.7×	289 0.6×	147 0.4×	378 0.9×	21	1.9k
Martin Puhr Austria	27	1.2k 1.2×	926 1.4×	791 1.6×	304 0.7×	786 2.0×	60	2.3k
Xiaoying Sun China	20	663 0.7×	787 1.2×	259 0.5×	376 0.9×	368 0.9×	50	1.6k
Juan A. Recio Spain	23	1.0k 1.0×	526 0.8×	296 0.6×	179 0.4×	215 0.5×	53	1.8k
Jeffrey Kiefer United States	24	1.2k 1.2×	588 0.9×	268 0.5×	180 0.4×	513 1.3×	60	2.0k
José A. López-Martín Spain	28	824 0.8×	1.3k 1.9×	601 1.2×	243 0.6×	352 0.9×	123	2.4k

Countries citing papers authored by Jun Ge

Since Specialization

Citations

This map shows the geographic impact of Jun Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ge more than expected).

Fields of papers citing papers by Jun Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ge. The network helps show where Jun Ge may publish in the future.

Co-authorship network of co-authors of Jun Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ge. A scholar is included among the top collaborators of Jun Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ge. Jun Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Lijun, Hongfang Liu, Li Chen, et al.. (2025). Distinct roles of HMOX1 on tumor epithelium and macrophage for regulation of immune microenvironment in ovarian cancer. International Journal of Surgery. 111(10). 6725–6742. 2 indexed citations

Ge, Jun, Kaige Liu, Hao Li, et al.. (2024). New insights into the intestinal barrier through “gut-organ” axes and a glimpse of the microgravity’s effects on intestinal barrier. Frontiers in Physiology. 15. 1465649–1465649. 12 indexed citations

Li, Hongkun, Jiawei Li, Yifan Zhang, et al.. (2024). The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway. Frontiers in Pharmacology. 15. 1401979–1401979. 3 indexed citations

Ren, Shengxiang, Jifeng Feng, Shenglin Ma, et al.. (2023). KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC. International Journal of Cancer. 153(3). 623–634. 12 indexed citations

Wang, Lu, Shenglong Le, Yifan Yang, et al.. (2022). A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease. Nature Communications. 13(1). 2555–2555. 89 indexed citations

Liu, Bin, Li Zeng, Jing Ding, et al.. (2021). Potential predictive value of plasma heat shock protein 90α in lung cancer. Journal of International Medical Research. 49(12). 3619125321–3619125321. 7 indexed citations

Tokheim, Collin, Xiaoqing Wang, Richard T. Timms, et al.. (2021). Systematic characterization of mutations altering protein degradation in human cancers. Molecular Cell. 81(6). 1292–1308.e11. 52 indexed citations

Li, Jingxin, et al.. (2021). Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 172. 108656–108656. 31 indexed citations

Shi, Sailing, Shengqing Gu, Wubing Zhang, et al.. (2020). Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors. Clinical Cancer Research. 26(22). 5990–6002. 45 indexed citations

10.

Sun, Dongqing, Jin Wang, Ya Han, et al.. (2020). TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Research. 49(D1). D1420–D1430. 689 indexed citations breakdown →

11.

Guo, Rui, Yongjun Wang, Mo Liu, et al.. (2019). The effect of quality of segmental bowel preparation on adenoma detection rate. BMC Gastroenterology. 19(1). 119–119. 28 indexed citations

12.

Hao, Qian, et al.. (2019). Etiologic Spectrum of Intestinal Obstruction in Ningxia District: A Retrospective Analysis of 4908 Cases in a 10-Year Period. Gastroenterology Research and Practice. 2019. 1–7. 4 indexed citations

13.

Si, Lu, Xiaoshi Zhang, Yongqian Shu, et al.. (2019). A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151). Translational Oncology. 12(6). 828–835. 99 indexed citations

14.

Zhang, Bo, et al.. (2018). Immune-related adverse events from combination immunotherapy in cancer patients: A comprehensive meta-analysis of randomized controlled trials. International Immunopharmacology. 63. 292–298. 77 indexed citations

15.

Feng, Shanshan, Bo Yang, Qianqian Li, et al.. (2018). The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells. PLoS ONE. 13(3). e0192208–e0192208. 6 indexed citations

16.

Yang, Yu, Yang Du, Cong Li, et al.. (2015). Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer Chemotherapy and Pharmacology. 75(4). 783–790. 11 indexed citations

17.

Ge, Jun, Hongfeng Gou, Ye Chen, et al.. (2013). Clinical Characteristics of Patients With Solitary Pulmonary Mass After Radical Treatment for Primary Cancers: Pulmonary Metastasis or Second Primary Lung Cancer?. Cancer Investigation. 31(6). 397–403. 8 indexed citations

18.

Ding, Jing, Jie Tang, Xin Chen, et al.. (2013). Expression Characteristics of Proteins of the Insulin-like Growth Factor Axis in Non-small Cell Lung Cancer Patients with Preexisting Type 2 Diabetes Mellitus. Asian Pacific Journal of Cancer Prevention. 14(10). 5675–5680. 18 indexed citations

19.

Tan, Benxu, W. Yao, Jun Ge, et al.. (2011). Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer. 117(22). 5103–5111. 144 indexed citations

20.

Peng, Xingchen, Meng Qiu, Benxu Tan, et al.. (2011). Different combination schedules of gemcitabine with endostar affect antitumor efficacy. Cancer Chemotherapy and Pharmacology. 69(1). 239–246. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact